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Phoneutria nigriventer spider accidental envenomation provokes neurotoxic manifestations, which when critical, results in
epileptic-like episodes. In rats, P. nigriventer venom (PNV) causes blood-brain barrier breakdown (BBBb). The PNV-induced
excitotoxicity results from disturbances on Na+, K+ and Ca2+ channels and glutamate handling. The vascular endothelial growth
factor (VEGF), beyond its angiogenic effect, also, interferes on synaptic physiology by affecting the same ion channels and protects
neurons from excitotoxicity. However, it is unknown whether VEGF expression is altered following PNV envenomation. We found
that adult and neonates rats injected with PNV showed immediate neurotoxic manifestations which paralleled with endothelial
occludin, 𝛽-catenin, and laminin downregulation indicative of BBBb. In neonate rats, VEGF, VEGF mRNA, and Flt-1 receptors,
glutamate decarboxylase, and calbindin-D28k increased in Purkinje neurons, while, in adult rats, the BBBb paralleled with VEGF
mRNA, Flk-1, and calbindin-D28k increases and Flt-1 decreases. Statistically, the variable age had a role in such differences,
which might be due to age-related unequal maturation of blood-brain barrier (BBB) and thus differential cross-signaling among
components of the glial neurovascular unit. The concurrent increases in the VEGF/Flt-1/Flk-1 system in the cerebellar neuron cells
and the BBBb following PNV exposure might imply a cytokine modulation of neuronal excitability consequent to homeostatic
perturbations induced by ion channels-acting PNV neuropeptides. Whether such modulation represents neuroprotection needs
further investigation.
1. Introduction
Accidents with venomous animals have been considered
a neglected health public issue. Accidents caused by
Phoneutria nigriventer, popularly known as the armed spider,
are common in Southeast Brazil. The majority of them
only cause pain, intense sudoresis, and local inflammation.
However, accidents graded as severe (less than 0.5%) cause in
addition cramps, tremors, blurred yellow vision, tachypnea,
cardiovascular alterations, priapism, and convulsion and
rarely death, those symptoms appearing to be more severe in
children [1, 2].
Experimental studies in rats showed that the clinical
symptoms of envenomation paralleled those of humans. Our
studies have shown that the Phoneutria nigriventer venom
induces blood-brain barrier breakdown through increased
vesicular transcellular transport [3] followed by upregulation
of the glycoprotein P (P-gp) efflux protein and by impairment
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of the paracellular pathway due to the displacement and
phosphorylation of junctional proteins [4]. Apart from that,
the venom induces vasogenic edema in hippocampus [5] and
cytotoxic edema in rat cerebellum [6], reactive gliosis in the
two regions [7], and neuronal activation (FOS+ induction) in
regions associated with stress and motor activity [8]. In the
cerebellum gray matter, mainly in the granular layer, PNV
upregulates the water channel aquaporin-4 [9], a protein
which regulates edema formation and resolution. All the
changes have a pace and tend to be restored with time.
The mechanism(s) underlying these effects is unknown, but
hypoxia secondary to the respiratory and cardiovascular
distress exhibited by animals could be a primary cause.
VEGF, an angiogenic cytokine which mediates vascular
permeability [10], has been reported to protect neurons in
adverse conditions by modulation of glutamatergic synap-
tic excitability and interference on Ca2+, K+, and voltage-
gated Na+ channels physiology [11–13]. In hippocampus, the
cytokine is considered an endogenous anti-convulsing factor
to preserve pyramidal neurons from hyperexcitability [14].
VEGF exerts its action through the binding and activation
of two transmembrane tyrosine kinase receptors: VEGFR-1
or Flt-1 [15] and VEGFR-2 or Flk-1 [16]. The receptors, in
turn, modulate the VEGF signals that affect different cellular
processes, so contributing for counteracting or aggravating
the noxious stimuli.
In the light of the above, the current study aimed at
determining whether the expression of VEGF, Flt-1, and Flk-
1 and respective mRNAs of cerebellar neurons is altered
in the course of BBB impairment caused by PNV in rats.
Age-related alterations were investigated in neonate and
young adult rats. We further analyzed the expression of
glutamate decarboxylase (GAD), responsible for the syn-
thesis of gamma-amino butyric acid (GABA) and of the
calcium-binding protein calbindin-D28k (CaB), a marker
of Purkinje cells. Such events were investigated because
postnatal development continues for several months in the
cerebellum and blood-brain barrier interface is immature
in neonates. Besides, BBB of cerebellum has been already
shown to be disrupted by PNV, and our hypothesis is that
changes in the expression of VEGF/Flt-1/Flk-1 system may
occur in parallel with BBB opening induced by ion channels-
acting P. nigriventer venom and those changes could be age
dependent.
2. Material and Methods
2.1. Ethics Statement. This study was approved by
the Institution’s Committee for Ethics in Animal Use
(CEUA/IB/Unicamp, protocol 2403-1) and the experiments
were carried out according to the Brazilian Society of
Laboratory Animal Science (SBCAL) guidelines for animal
use.
2.2. Venom. PNV was obtained by the electrical stimulation
of spiders living inArachnid Laboratory at theDepartment of
Biology, IBS, UFMG, Belo Horizonte, MG, Brazil, and stored
at −20∘C until use.
2.3. Animals and Envenoming Procedure. Male Wistar rats
(Rattus norvegicus) were obtained from an established colony
maintained by the Central Animal House Service at Unicamp
(CEMIB/Unicamp) and housed under standard laboratory
conditions. Rats aged 14 days (P14 animals—neonate group)
and 8–10 weeks (adult group) were used; they received a
single intraperitoneal (i.p.) injection of PNV (1.7mg/kg in
0.5mL of 0.9% sterile saline solution), while to control groups
the same volume of vehicle was given. PNV concentration
was selected based on previous laboratory studies [9, 17].
Neonate rats were used for comparison with adult rats, since
severe accidents byPhoneutria generally occur in children [1].
Time limits of 2, 5, and 24 hours corresponded to periods of
peak of intoxication, beginning of clinical recovery, and no
sign of intoxication at all, respectively [17].
2.4. Evaluation of Blood-Brain Barrier (BBB) Permeability.
The integrity of the BBB was determined using Evans blue
extravasation method. Briefly, 10mL/kg of Evans blue (Vetec
Quı´mica, Duque de Caxias, RJ, Brazil) dye solution (2% in
0.9% saline) was injected into the tail vein of adult rats (i.v.)
at 2, 5, and 24 hours after i.p injection of 0.9% saline or PNV
(1.7mg/kg). Fifteen minutes after Evans blue injection, the
rats were killed with an overdose of anesthetics and brain and
cerebellum were rapidly removed and photographed.
2.5. Immunohistochemistry. At designated time intervals and
after anesthesia, the animals (𝑛 = 4/time interval, 𝑛 =
12 control, and 𝑛 = 12 PNV-treated per age) were per-
fused transcardially with saline solution followed by 4%
paraformaldehyde in 0.1M PBS (phosphate buffered saline),
pH 7.4. The cerebella were dissected out and were embedded
in paraffin. Antibodies utilized were anti-VEGF (1 : 50, sc-
7269), anti-Flt-1 (1 : 500, sc-316), and anti-Flk-1 (1 : 50, sc-315),
all from Santa Cruz Biotechnology (Santa Cruz, CA, USA),
CaB (1 : 1000, C2724, Sigma-Aldrich, St. Louis, MO, USA),
and GAD (1 : 500, AB1511, Millipore, Billerica, MA, USA).
Immunohistochemistry was performed in sequential coronal
5 𝜇m thick paraffin sections of the cerebellum as previously
described [17]. To avoid procedure differences between con-
trol and envenomed groups, the immunohistochemistry for
each protein (VEGF/Flt-1/Flk-1 and CaB/GAD) was per-
formed concomitantly. Three images per region (molecular,
granular, and Purkinje) of 𝑛 = 4 rats, totaling 12 images per
time/age/treatment, were captured using a BX51 microscope
(Olympus Optical C. Ltd., Tokyo, Japan). Objective (20x),
lens aperture, and light intensity were set for all images
captured.
2.6. Western Blot (WB). Standard Western blot analysis [4]
of cerebellum lysates (𝑛 = 6/time interval, 𝑛 = 18
control, and 𝑛 = 18 PNV treated per age) was performed
using rabbit polyclonal antibody against CaB (1 : 2000, C2724,
Sigma-Aldrich, St. Louis, MO, USA), Flt-1 (1 : 500, sc-316),
Flk-1 (1 : 250, sc-315), both from Santa Cruz Biotechnology
(Santa Cruz, CA, USA), GAD (1 : 1000, AB1511, Millipore,
Billerica, MA, USA) and laminin (1 : 500, L9393, Sigma-
Aldrich, St. Louis, MO, USA), mouse monoclonal antibody
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against VEGF (1 : 500, sc-7269) and 𝛽-Catenin (1 : 600, sc-
7963), both from Santa Cruz Biotechnology (Santa Cruz,
CA, USA) and 𝛽-actin (1 : 1000, A2228, Sigma-Aldrich, St.
Louis, MO, USA) and goat monoclonal antibody against
occludin (1 : 500, sc-8144, Santa Cruz Biotechnology, Santa
Cruz, CA, USA). Bands were visualized using chemilumi-
nescence reagent (Thermo Scientific, Waltham, MA, USA).
For quantification, the density of pixels of each band was
determined by the NIH Image J 1.45s software (available
at http://rsb.info.nih.gov/nih-image; developed by Wayne
Rasband, NIH, Bethesda, MD). For each protein investigated
the results were confirmed in three sets of experiments and
data were normalized using the respective loading controls.
Values were normalized to the corresponding value for 𝛽-
actin internal control and expressed as a ratio.
2.7. RNA Isolation and Real-Time Quantitative Reverse
Transcription-PCR (qPCR). Total RNAwas isolated from the
cerebellumof each group (𝑛 = 4/time interval, 𝑛 = 12 control,
and 𝑛 = 12 PNV treated per age) using Trizol reagent (Life
Technologies, Gaithersburg, MD, USA). Primers used in this
study and their respective assay identification numbers in
theApplied Biosystem cataloguewereVEGF: Rn01511601 m1,
Flt-1: Rn00570815 m1, Flk-1: Rn00564986 m1. The levels of
VEGF, Flt-1, and Flk-1 mRNAs were calculated relative to
amplicon-specific standard curves by qPCR using 50 ng total
RNA in triplicate and analyzed on an ABI Prism 7500
sequence detector, using a TaqMan Universal Master Mix.
The optimal concentrations of cDNA and primers, as well as
the maximum efficiency of amplification, were obtained by
five-point, twofold dilution curve analysis for each gene. Each
PCR contained 3.0 ng of reverse-transcribed RNA, 200 nM
of each specific primer, SYBR SAFE PCR master mix, and
RNAse-free water to a final volume of 20 𝜇L. All samples
were run in triplicate with water as a no-template control
and GAPDH as an endogenous control. Real-time data were
analyzed using the Sequence Detection System 1.7 (Applied
Biosystems).
2.8. Statistics. Data were assessed by a three-way ANOVA
to compare the variables: treatment (saline treated and PNV
treated), age (P14 and 8–10 weeks), and time (2, 5, and
24 hours). Groups’ comparison was done using unpaired
Student’s t-test. The results were expressed as the mean ±
SEM. Values of 𝑃 ≤ 0.05 indicate significance.
3. Results
Animals of both ages injected with saline solution were alive
and exhibited no sign of discomfort. Animals injected with
PNV showed neurotoxic manifestation as described else-
where [5]. P14 rat excitotoxic effects were more precocious
than in adult rats, but the recovery was delayed relative to
adults. Nevertheless, signs of recovery of intoxication started
5 hours after envenoming; one adult and one neonate rat died.
3.1. Blood-Brain Barrier Permeability. Control rats (saline
injected) that received i.v. infusion of Evans blue showed
absence of any blue color on the brain surface or in the
interior of cerebellum hemispheres which indicaes that there
is no extravasation of Evans blue dye from microvasculature
circulation (Figures 1(a) and 1(b)). On the contrary, PNV-
treated rats showed brain and cerebellum surface and cere-
bellum interior shaded blue which indicates disruption of
microvascular blood bed and leakage of Evans blue (Figures
1(c) and 1(d)). The leakage of Evans blue was detected at 2
hours, but not at 5 and 24 hours suggesting BBB return to
integrity (not shown).
3.2. BBB Assessment: PNV Decreased Transiently Occludin, 𝛽-
Catenin, and Laminin. All the three BBB-associated proteins,
occludin from tight junction, 𝛽-catenin from adhesion junc-
tion, and laminin from the endothelial basal membrane, were
decreased significantly by 34%, 35%, and 36%, respectively, 2
hours after administration of PNV to neonates. In adult rats,
PNV induced a 33% decrease of occludin at 2 hours followed
by 23% increase at 24 hours and 60% decrease of 𝛽-catenin
at 2 hours and did not alter laminin expression (Figures
2(a) to 2(c)). The changes were transitory in animals of both
ages.
Age-related changes showedoccludin and𝛽-catenin basal
level lower in saline-injected neonate rats at 2 hours relative
to adult rats. Moreover, baseline expression of laminin was
lower in neonates at 5 hours and higher at 24 hours compared
to adults. In envenomed rats, occludinwas higher in adult rats
at 5 hours than in P14 rats.
Immunohistochemistry: PNV Increased the VEGF, Flt-1, and
Flk-1 Reactivity. In P14 and adult controls, VEGF immuno-
labeling was weakly detected in the perikaryum, outlining
the cell profile of Purkinje cells (PCs); the nucleus was
negative. Some cells in themolecular (ML) and granular layer
(GL) were stained (Figure 3(a)). PNV-administered animals
induced anti-VEGF staining in the nucleus and increased it in
the somata and marginal cytoplasm of PCs (Figure 3(b)). In
addition, delicate VEGF+ tangled cell processes were labeled
within the ML. Cells in the GL and ML remained VEGF
negative. The labeling pattern was fairly similar throughout
time; however, the intensity of the reaction was marginally
strongest at 24 hours.
In the cerebellum of controls, the anti-Flt-1 and anti-
Flk-1 reactivity was seen in the PC nucleus and perikaryum
or only in the peripheral perikaryum; a number of stained
nuclei were labeled within the ML and GL (Figures 3(c) and
3(e)). PNV upregulated Flt-1 and Flk-1 level at all times in
cells throughout the cerebellar cortex such as in the PCs’
nuclei, somata, and peripheral cytoplasm, in nuclei within
the GL and ML, and in straight-lined processes present
in the ML; in envenomed rats, regions of glomeruli were
wider and density of glomerular neurons seemed lower than
in controls in some parts of the GL (Figure 3(d)). Flk-1
upregulation was not as intense as for Flt-1 (compare Figures
3(e) and 3(f)). Flt-1 and Flk-1 staining increased with time,
but visually no obvious difference in the intensity of the
labeling could be perceived between P14 and adults (not
shown).
4 BioMed Research International
(a) (b)
(c) (d)
Figure 1: Representative photographs of brain and cerebellum from adult rats injected with Evans blue 2 hours after administration of saline
((a) and (b)) or Phoneutria nigriventer venom ((c) and (d)). (a) and (c) show dorsal brain surface. (b) and (d) show interior of cerebellum
hemispheres.
3.3. Western Blot and Real-Time PCR. VEGF, Flt-1, and Flk-
1 expressions were higher in neonates than in adult animals,
both basally and after envenomation. PNV altered level of the
proteins and respective mRNAs but the dynamics of changes
differed between neonates and adults.
Throughout the time interval examined, VEGF, Flt-1, and
Flk-1 expressions were significantly higher in neonates than
in adults, both controls and envenomed (Figures 4(a) to 4(c)).
However, Flk-1 mRNA was higher in adults, both controls
and envenomed, than in neonates at all three time points
(Figure 5(c)).
PNV induced an 18% increase of VEGF expression in
P14 animals at 5 hours (Figure 4(a)). VEGF mRNA content
was quite similar in control and envenomed neonates and
adults (Figure 5(a)), except at 5 and 24 hourswhen therewas a
twofold increase for neonates and an 18% increase for adults.
In relation to VEGF receptors, PNV caused an immediate
50% increase in the Flt-1 level in P14 rats (2 hours) that
changed to 14% increase at 5 hours and 11% increase at 24
hours above baseline (Figure 4(b)). In contrast, in adult rats
PNV promoted decreases in the level of Flt-1, 25% at 2 hours,
and 93% at 5 hours followed by recovery to baseline values at
24 hours. In neonate and adult rats, Flt-1 mRNA expression
was unaffected by PNV exposure (Figure 5(b)). PNV did not
alter the expression of the Flk-1 and its mRNA in neonates
(Figures 4(c) and 5(c)) but increased Flk-1 expression in
adults at 5 hours.
The three-way analysis of variance showed that variables
treatment versus age versus time influenced VEGF mRNA
expression (∗𝑃 ≤ 0.05) and Flt-1 receptor expression
(∗𝑃 ≤ 0.05). In addition, there was interaction between
treatment versus age for the Flt-1 receptor (∗∗∗𝑃 ≤ 0.001) and
treatment versus time for VEGF (∗𝑃 ≤ 0.05).
PNV increased CaB in neonate and adult rats while GAD
was increased only in neonate rats.
In controls, adult and neonate, the Purkinje cell-
specific calcium-binding protein, calbindin-D28k, was
expressed in the nucleus, cytosol, and dendritic tree of PCs
(Figure 6(a)). Following PNV injection anti-CaB labelingwas
stronger particularly in PCdendrites extending across theML
(Figure 6(b)). Western blot analyses confirmed that PNV
induced a 16% significant upregulation of the protein at
24 hours in neonates and a 9% increase at 5 hours in adult
rats (Figure 6(c)). The baseline expression of CaB was
significantly higher in neonates than in adults at 2 hours
(23%); also the PNV-induced CaB expression was higher in
neonates than in adults at 2 hours (25%) and 24 hours (28%).
The three-way analysis of variance showed that the variables
treatment versus age versus time influenced CaB expression
(∗∗𝑃 ≤ 0.01).
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Figure 2: Immunoblots of occludin (a), 𝛽-Catenin (b), and laminin (c) show lower expression of the proteins in the cerebella lysates of
envenomed animals relative to controls. Data are means ± SEM; ∗𝑃 ≤ 0.05; ∗∗𝑃 ≤ 0.01 ∗∗∗𝑃 ≤ 0.001 relative to controls; #𝑃 ≤ 0.05;
##
𝑃 ≤ 0.01 relative to corresponding adults at the same time interval. Unpaired Student t-test.
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Figure 3: Photomicrographs of cerebellar cortex of rats aged 14 days 5 hours after administration of saline solution ((a), (c), and (e)) or
Phoneutria nigriventer venom (PNV) ((b), (d), and (f)). PNV increased VEGF (b), Flt-1 (d), and Flk-1 (f) labeling.ML =molecular layer; PC =
Purkinje cells, and GL = granular layer. Arrows point Purkinje cells positive for VEGF, Flt-1, and Flk-1; triangles show nonuniformly scattered
labeled nuclei inside the molecular layer. Bars = 25𝜇m for all panels. Inserts illustrate the expression of Flt-1 receptor in the endothelium
nuclei, whereas Flk-1 receptor is expressed in nuclei and cytoplasm of endothelial cells of envenomed rats (Bars = 10 𝜇m (d) and 25𝜇m (f)).
GABA signaling was altered in PNV-administered rats,
given the expression of GAD, responsible for GABA syn-
thesis, and was noticeably increased in PCs somata and
dendritic tree (Figures 6(e) and 6(f)). Immunoblots showed
that the GAD protein expression of treated P14 rats was 10%
upregulated at 2 hours and remained practically unchanged
thereafter (Figure 6(g)). In adult rats exposed to PNV,
GAD remained unchanged compared to baselines values
(Figure 6(h)).There was an age-related difference at 24 hours
withGAD expression of PNV-treated neonate rats surpassing
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Figure 4: VEGF (a), Flt-1 (b), and Flk-1 (c) graph representation of western blot signals after densitometric measurement and normalization
to internal 𝛽-actin at time points after PNV (1.7mg/kg) or 0.9% saline i.p. injection. Data are means ± SEM. ∗𝑃 ≤ 0.05 and ∗∗𝑃 ≤ 0.01 in
relation to controls; #𝑃 ≤ 0.05, ##𝑃 ≤ 0.01, and ###𝑃 ≤ 0.001 in relation to corresponding adults at the same time interval. Unpaired Student
t-test was used.
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Figure 5: Quantitative real-time PCR analysis quantified and normalized to endogen control (GAPDH). VEGF (a), Flt-1 (b), and Flk-1 (c)
mRNAs expression at time points after PNV (1.7mg/kg) or 0.9% saline i.p. injection. ∗∗𝑃 ≤ 0.01 and ∗∗∗𝑃 ≤ 0.001 indicate significant
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Figure 6: Continued.
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Figure 6: CaB and GAD immunohistochemistry in the cerebellar cortex of rats aged 14 days after i.p. injection of saline solution ((a) and (e))
or P. nigriventer venomPNV ((b) and (f)). (a) and (b) showCaB labeling (24 hours after saline or PNV exposure, resp.) in Purkinje cell bodies,
including nuclei (arrows) and processes crossing the molecular layer (ML). (c) and (d) show immunoblots and representative histograms of
the densitometric CaB values of rats injected with saline (A) or PNV (C) at different time points. (e) and (f) show GAD labeling in Purkinje
cell bodies and cell processes within themolecular layer (arrow).The physiologic GAD labeling was weak in controls (e) whereas it was strong
in envenomed animals (f). (g) and (h) show immunoblots and representative histograms of the densitometric GAD values of rats injected
with saline (E) or PNV (G) at different time points (𝑛 = 6/time). The membranes were stripped and reprobed to 𝛽-actin, confirming equal
protein loading in the gel ((B), (D), (F), and (H)). Values are mean ± SEM; unpaired Student t-test. ∗𝑃 ≤ 0.05; ∗∗𝑃 ≤ 0.01; ∗∗∗𝑃 ≤ 0.001
compared to control at each time point; #𝑃 ≤ 0.05; ##𝑃 ≤ 0.01; ###𝑃 ≤ 0.001 compared to corresponding adults at the same time interval. P =
pia mater; PC = Purkinje cells; ML = molecular layer; GL = granular layer. Bars = 25 𝜇m for all panels.
by 15% that of PNV-treated adults. The three-way analysis of
variance showed interaction only between treatment versus
age (∗∗∗𝑃 ≤ 0.001).
4. Discussion
The present findings show that prominent increases of VEGF
and receptor Flt-1 in cerebellar neurons course with neuro-
toxic effects caused by PNV in P14 rats. This is accompanied
by upregulations of VEGF mRNA, CaB, and GAD. The data
suggest that, upon systemic presence of PNV, endogenous sig-
naling mechanisms may have activated transcription factors
and promote proteins translational regulation in newborn
rats.
The alterations involving the VEGF-Flt-1 binding in
neonate rats were concurrent with prominent decreases of
the proteins associated with BBB endothelium: occludin, 𝛽-
catenin, and laminin. The data corroborate previous stud-
ies showing PNV-induced BBB permeation in adult rats
[3–6], now reaffirmed by the extravasation of Evans blue
injected peripherally. Herein, the time course data over a
period of 2 hours to 24 hours revealed that expressional
decreases of occludin, 𝛽-catenin, and laminin (at 2 hours)
were simultaneous with the peak of Flt-1 upregulation (50%)
but preceded the PNV-induced significant increases of VEGF
and VEGF mRNA, which occurred later at 5 hours after
PNV. Also, at 5 hours, occludin, 𝛽-catenin, and laminin levels
were recovered markedly relative to corresponding control
levels, which paralleled with content of VEGF and Flt-1
significantly above baseline. Such data disclose what seems to
be a coordinated sequence of molecular events, which began
with the BBB breakdown, and proceeded with increases of
Flt-1, VEGF, and VEGF mRNA. The transient disturbance of
BBB-associated proteins in P14 rats might be due to the fact
that VEGF receptors once activated trigger signals directed to
endothelial cells [18] and neuron cell [19], either to accentuate
permeability [20–22] and/or to restore homeostasis.
Curiously, in contrast to neonates, PNV induced
decreases over time of Flt-1 in adult rats reaching ∼93%
downregulation at 5 hours, which though was transient
and shows great capacity for recovery since at 24 hours the
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baseline level had been already reached. Consistent with
this, at the same 24 hours, VEGF mRNA was significantly
increased. However, PNV increased cerebellar Flk-1 and
CaB at 5 hours, a time point in which BBB functionality
had been restored as indicated by absence of extravasation
of Evans blue dye. Interestingly, 5-hour time coincides with
the beginning of the adult animals’ recovery from neurotoxic
manifestations caused by PNV [4, 6].
VEGF, Flt-1, and Flk-1 protein expressions were also
detected by immunohistochemistry. The three proteins were
constitutively present in Purkinje neurons and their dendritic
processes extended across the ML in control animals. The
exposure to PNV induced visible increases in the Purkinje
neurons’ immunoreactivity over a period of 2 to 24 hours;
interestingly, nonuniformly dispersed cells within the GL
and ML also showed increases in the Flt-1 and Flk-1 reac-
tivity in envenomed P14 and adult rats. We do not know
whether such cells are astrocytes and/or neurons. Studies
have shown that VEGF and Flk-1 can be expressed by granule
neurons during postnatal development of cerebellum [23–25]
and by astrocytes under normal or pathological conditions
[26–29]. Astrocytes also express Flt-1, but as far as we know
there is no mention in the literature on Flt-1 expression
by cerebellar granule cells. Since the ML is characterized
by extensive synaptic contacts between granule neurons,
interneurons, Begmann glia, and Purkinje neurons [30], it is
conceivable that activation of a given cell may elicit a chain of
stimuli in the others. The induction of VEGF and receptors
in neurons and probably in astrocytes supports previous
evidence showing these cells as targets of PNV concurrently
with BBB dysfunction [3–9, 17].
VEGF family members, traditionally known as potent
inducers of angiogenesis, have been recently recognized to
exert various nonangiogenic effects on different cell types,
amongwhich there are neuron cells [13]. VEGF and receptors
have been recognized as an important element for neu-
ron survival and maintenance of endothelium in adults.
It acts in the nervous system both through vascular and
neuronal mechanisms. Molecules that dually affect both
neural and vascular (neurovascular) functions are referred
to as angioneurins; their action includes regulation of angio-
genesis, BBB integrity, vascular perfusion, neuroprotection,
neurodegeneration, and synaptic plasticity [31]. The pro-
tection of neurons by VEGF is exerted by interference on
Ca2+, K+, and voltage-gated Na+ channels physiology and
modulation of glutamatergic synaptic excitability [11–13].
VEGF inhibits outward delayed K+ currents and reduces
Ca2+ influx through the high-voltage-activated Ca2+ chan-
nels; the cytokine also inhibits Na+ currents in cultured rat
hippocampal neurons, thus modulating neuron excitability.
In hippocampus, the cytokine is considered an endogenous
anticonvulsing factor to preserve pyramidal neurons from
hyperexcitability [14]. The interference of PNV peptides in
calcium homeostasis and glutamate handling have been well-
documented [32–36]. Herein, we found signs that PNV
disturbed calcium buffering in Purkinje neurons. P14 and
adult rats treated with PNV increased CaB immunoreactivity
in the PC’s nucleus, perikaryum, and dendritic ramification,
which was confirmed by the WB data showing upregu-
lation of the protein. Because PCs are the only output
cell of the cerebellar cortex and because CaB functions as
a calcium buffer, the changes in the PC’s immunoreactivity
and level of the protein in the cerebellum lysates suggests
implication on PC functional changes related with PNV
effect.
PNV induced an immediate, but transient, increase of
GAD expression in neonate rats, while in adults it was unaf-
fected. The key synthesizing isoforms for GABA, GAD types
65 and 67, were decreased in the Purkinje cells of neonate
rats but not in adult rats treated with PNV. This suggests
that the decarboxylation of glutamate to the major inhibitory
neurotransmitter GABA supports the view that synaptic
inhibition is vital for the control of neuron excitability in the
central nervous system and a dynamic mechanism to restore
brain homeostasis, when disturbed by neurotoxic peptides of
PNV.The increase ofGAD in neonate rats in response to PNV
is in accordance with the major level of VEGF both basically
and after PNV treatment in neonate than in adult rats
(see Figure 4). Whether the increase of VEGF promoted by
PNV, mainly seen in neonate rats, was a way to preserve
neurons [11, 12] against the glutamate toxicity generated
by PNV is uncertain. Nevertheless, it is well-known that
the postnatal development of cerebellum continues during
months after birth [37], which requires active angiogenesis,
neurogenesis, and cell migration. These cell processes are
regulated by angioneurins, that is, growth factors that act
both in neural an vascular cells, like VEGF and receptors
[10, 13, 19]. In contrast, angiogenesis, neurogenesis, and cell
migration are very discrete or switched off in adult animals.
Thismight explain the relative lower expression of VEGF and
receptors of cerebellum in adult animals, what could imply a
mature BBB able to better stand the toxic effects. In addition,
the BBB in neonate rats is undergoing postnatal development
[38], what could explain why junctional proteins remains
below baseline at 24 h in P14 rats whereas it is above baseline
in adult rats. It could be the reason why systemic PNV
increases even more the expression of VEGF and its mRNA
(at 5 hours) and the receptors Flt-1 (from 2 to 24 hours)
for neonates and transiently decreases Flt-1 expression but
does not alter VEGF and only increases VEGF mRNA at
24 h in adults. Interestingly, PNV causes release of kallikrein
[39], and kallikrein causes BBB breakdown [40]. VEGF and
kallikrein share a series of effects such as enhancing the
survival and migration of neuronal and glial cells, promoting
angiogenesis, protecting against ischemia, apoptosis, and
glutamate-induced neurotoxicity [41]. However, we do not
know if kallikrein released by PNV is able to increase
VEGF.
5. Conclusions
VEGF and PNV have in common to act on BBB-enhanced
permeability, interfere in ion channels physiology, affect
synaptic plasticity, and disturb glutamatergic transmission.
Here, we found that the evolution of the toxic manifestations
exhibited by rats injected with PNV seems to be time-related
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to the dynamics of immunochemical content of VEGF, Flt-
1, and Flk-1 and respective mRNAs and CaB and GAD in
the cerebellum. Age-related differences with neonate rats
apparently were also found more susceptible to PNV than
adult rats. Future studies are needed to determine whether
VEGF and tyrosine kinase intracellular domains changes in
Purkinje cells underlie BBB disturbances as a consequence
of venom effect or a causal factor mediating the venom’s
homeostatic perturbations. Ionic and glutamate disturbances,
induced by PNV, affect synaptic extracellular compartments
and neuronal signaling and could underlie the neurotoxic
manifestations of animals. Whether the increase of VEGF
in neurons represents protective modulation of synaptic
excitability and of Ca2+, K+, and Na+ channels functioning
is a matter to be elucidated.
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